Value proposition

Delta4 is a Vienna-based biotech startup driving the forefront of digital drug discovery and development.

Delta4 is driving the forefront of digital drug discovery and development. We leverage a proprietary computational analytics platform "Hyper-C", combining straightforward biomedical testing and clinical validation of candidate drugs.

Our unique approach integrates iterative big data/in silico and experimental screens, offering the most efficient matching of clinical indications and compound/drug effects.

drug repositioning, drug discovery, compounds, orphan diseases, indication expansion, AI, and omics